Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Pain Med ., 17 , 572581
Hidden costs matter too
In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
Its stability in the digestive environment also allows it to be effective when taken orally, making it well-suited for gut-focused protocols
US$ 25.72
US$ 22.54
US$ 22.18
US$ 23.13
US$ 23.80
